← Eichor
Study identifier: NCT06533215 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Antimicrobial Efficacy of Nano-Based ICM on E.F

Condition: Enterococcus Faecalis Infection · Endodontically Treated Teeth · Endodontic Disease  ·  Sponsor: Tanta University

PhaseNA
Planned participants30
Who can joinAll sexes, 19 Years to 60 Years
Healthy volunteersYes

About this study

This in-vivo study aims to evaluate the antimicrobial effect of nano based intracanal medications (Triple antibiotic-loaded chitosan nanoparticles and chlorohexidine loaded by silver nanoparticles) on Enterococcus faecalis count reduction in secondary endodontic infection cases.

This description comes directly from the study's public registry record.

Talk to the study team

Ibrahim Ali, bachelor  ·  +201021294204  ·  ibrahim3lii1995@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Faculty of DentistryTanta, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06533215